Lexicon completes SONATA-HCM enrollment, eyes 2027 sotagliflozin data

Lexicon Pharmaceuticals said it completed enrollment in the SONATA-HCM trial of sotagliflozin, with data expected in 2027.

Detected & updated continuously · Source: Nebula